RVL Pharmaceuticals PLC (RVLPQ)
0.00
USD |
OTCM |
May 22, 16:00
RVL Pharmaceuticals Gross Profit Margin (Quarterly): 76.44% for June 30, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 76.44% |
| March 31, 2023 | 73.97% |
| December 31, 2022 | 73.90% |
| September 30, 2022 | 74.81% |
| June 30, 2022 | 73.64% |
| March 31, 2022 | 90.00% |
| December 31, 2021 | 62.13% |
| September 30, 2021 | 47.77% |
| June 30, 2021 | 93.84% |
| March 31, 2021 | 27.38% |
| December 31, 2020 | -32.07% |
| September 30, 2020 | 95.40% |
| Date | Value |
|---|---|
| June 30, 2020 | -11.54% |
| March 31, 2020 | 57.68% |
| December 31, 2019 | 62.49% |
| September 30, 2019 | 58.28% |
| June 30, 2019 | 43.26% |
| March 31, 2019 | 48.88% |
| December 31, 2018 | 42.79% |
| September 30, 2018 | 49.72% |
| June 30, 2018 | 53.14% |
| March 31, 2018 | 43.88% |
| December 31, 2017 | 37.35% |
| September 30, 2017 | 60.06% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-32.07%
Minimum
Dec 2020
95.40%
Maximum
Sep 2020
56.90%
Average
62.49%
Median
Dec 2019
Gross Profit Margin (Quarterly) Benchmarks
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -145.6% |
| Return on Assets | -56.40% |
| Return on Invested Capital | -67.49% |
| Profit Margin (Quarterly) | -289.3% |
| Operating Margin (Quarterly) | -98.34% |
| Return on Net Operating Assets | -87.86% |